Stand Up To Cancer-funded Clinical Trials

Stand Up to Cancer-funded clinical trials are underway at Johns Hopkins.  They include trials for:

• lung cancer - Epigenetic Therapy for Patients with Surgically Resected Early Stage Lung Cancer
• lung cancer - MS 275 in Combination with 5-azacytidine in Patients with Recurrent Advanced Non-Small Cell Lung Cancer
• pancreatic cancer - Hydroxychloroquine in Combination with Gemcitabine/Abraxane